{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T05:42:07Z","timestamp":1674106927705},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1987,9,1]],"date-time":"1987-09-01T00:00:00Z","timestamp":557452800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[1987,9,1]],"date-time":"1987-09-01T00:00:00Z","timestamp":557452800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["La Ricerca Clin. Lab."],"published-print":{"date-parts":[[1987,9]]},"DOI":"10.1007\/bf02886916","type":"journal-article","created":{"date-parts":[[2021,12,14]],"date-time":"2021-12-14T13:51:34Z","timestamp":1639489894000},"page":"331-341","source":"Crossref","is-referenced-by-count":1,"title":["Interferon treatment of chronic hepatitis B surface antigen (HBsAg) carriers. A description of the activation profiles of natural killer cells obtained with different schedules of administration in three subsets of carriers"],"prefix":"10.1007","volume":"17","author":[{"given":"Giovanni Clemente","family":"Actis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleonora","family":"Maran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgio","family":"Saracco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Floriano","family":"Rosina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizia Rossana","family":"Brunetto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"Baldi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valter","family":"Lattore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Rocca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ferruccio","family":"Bonino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Rizzetto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgio","family":"Verme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02886916_CR1","unstructured":"BMDP Statistical Software. University of California Press, Los Angeles, 1981. BMDP2V, p. 359."},{"key":"BF02886916_CR2","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/0016-5085(86)90395-1","volume":"90","author":"F. Bonino","year":"1986","unstructured":"Bonino F., Rosina F., Rizzetto M., Rizzi R., Chiaberge E., Tardanico R., Callea F., Verme G.: Chronic hepatitis in HBsAg carriers with serum HBV-DNA and anti-HBe \u2014 Gastroenterology90, 1268, 1986.","journal-title":"Gastroenterology"},{"key":"BF02886916_CR3","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.4049\/jimmunol.131.3.1531","volume":"131","author":"J. F. Bukovski","year":"1983","unstructured":"Bukovski J. F., Woda B. A., Habu S., Okumura K., Welsh R.: NK depletion enhances virus synthesis and virus-induced hepatitisin vivo \u2014 J. Immunol.131, 1531, 1983.","journal-title":"J. Immunol."},{"key":"BF02886916_CR4","first-page":"9","volume-title":"Chronic active hepatitis (the Mayo Clinic experience)","author":"A. J. Czaja","year":"1986","unstructured":"Czaja A. J.: Natural history of chronic active hepatitis. In:Czaja A. J., Dickson E. R. (Eds): Chronic active hepatitis (the Mayo Clinic experience). M. Dekker, New York, 1986; p. 9."},{"key":"BF02886916_CR5","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/0016-5085(86)90087-9","volume":"90","author":"J. S. Dooley","year":"1986","unstructured":"Dooley J. S., Davis G. L., Peters M., Waggoner J. G., Goodman Z., Hoofnagle J. H.: Pilot study of recombinant human \u03b1-interferon for chronic type B hepatitis \u2014 Gastroenterology90, 150, 1986.","journal-title":"Gastroenterology"},{"key":"BF02886916_CR6","first-page":"158","volume":"4","author":"G. M. Dusheiko","year":"1984","unstructured":"Dusheiko G. M., Dibisceglie A., Bowyer S., Sacks F., Kew M. C.: Prolonged recombinant leukocyte \u03b1-IFN treatment of chronic hepatitis B \u2014 Hepatology4, 158, 1984.","journal-title":"Hepatology"},{"key":"BF02886916_CR7","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1002\/hep.1840060525","volume":"6","author":"T. Ikeda","year":"1986","unstructured":"Ikeda T., Lever A., Thomas H. C.: Evidence for a deficiency of interferon production in patients with chronic hepatitis B virus infection acquired in adult life \u2014 Hepatology6, 962, 1986.","journal-title":"Hepatology"},{"key":"BF02886916_CR8","first-page":"2480","volume":"42","author":"E. Lotzova","year":"1982","unstructured":"Lotzova E., Savary C. A., Gutterman J. U., Hersh E. M.: Modulation of natural killer cell-mediated cytotoxicity by partially purified and cloned IFN-\u03b1 \u2014 Cancer Res.42, 2480, 1982.","journal-title":"Cancer Res."},{"key":"BF02886916_CR9","doi-asserted-by":"crossref","first-page":"503","DOI":"10.4049\/jimmunol.131.1.503","volume":"131","author":"A. E. Maluish","year":"1983","unstructured":"Maluish A. E., Ortaldo J. R., Sherwin S.: Depression of NK cytotoxicity afterin vivo administration of recombinant leukocyte interferon \u2014 J. Immunol.131, 503, 1983.","journal-title":"J. Immunol."},{"key":"BF02886916_CR10","first-page":"5","volume":"1","author":"G. Martz","year":"1985","unstructured":"Martz G.: Editorial \u2014 Advanc. therapeut. Commun.1, 5, 1985.","journal-title":"Advanc. therapeut. Commun."},{"key":"BF02886916_CR11","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1159\/000199107","volume":"30","author":"N. Matsumara","year":"1984","unstructured":"Matsumara N., Yoshikawa T., Kondo M., Imanishi J., Kishida T.: Effect of low dosage of IFN on NK activity in patients with HBsAg-positive chronic active hepatitis \u2014 Digestion30, 195, 1984.","journal-title":"Digestion"},{"key":"BF02886916_CR12","first-page":"874","volume":"45","author":"J. R. Neefe","year":"1985","unstructured":"Neefe J. R., Sullivan J. E., Ayoob M., Phillips E., Smith F. P.: Augmented immunity in cancer patients treated with \u03b1-interferon \u2014 Cancer Res.45, 874, 1985.","journal-title":"Cancer Res."},{"key":"BF02886916_CR13","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1600-0676.1984.tb00925.x","volume":"4","author":"F. Negro","year":"1984","unstructured":"Negro F., Chiaberge E., Olivero S., Hammer M., Berninger M., Canese M. G., Bonino F.: Hepatitis B virus DNA in anti-HBe positive sera \u2014 Liver4, 177, 1984.","journal-title":"Liver"},{"key":"BF02886916_CR14","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/S0016-5085(85)80002-0","volume":"88","author":"M. Omata","year":"1985","unstructured":"Omata M., Imazeki F., Yokoshuka O., Ito Y., Uchiumi K., Mori J., Okuda K.: Recombinant leukocyte \u03b1-interferon treatment in patients with chronic hepatitis B virus infection \u2014 Gastroenterology88, 870, 1985.","journal-title":"Gastroenterology"},{"key":"BF02886916_CR15","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4049\/jimmunol.119.4.1351","volume":"119","author":"J. R. Ortaldo","year":"1977","unstructured":"Ortaldo J. R., Bonnard G. D., Herberman R. B.: Cytotoxic reactivity of human lymphocytes culturedin vitro \u2014 J. Immunol.119, 13, 1977.","journal-title":"J. Immunol."},{"key":"BF02886916_CR16","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/hep.1840060303","volume":"6","author":"M. Pignatelli","year":"1986","unstructured":"Pignatelli M., Waters J., Brown D.: HLA class I antigens on the hepatocyte membrane during recovery from acute hepatitis B virus infection and during interferon therapy in chronic hepatitis B virus infection \u2014 Hepatology6, 349, 1986.","journal-title":"Hepatology"},{"key":"BF02886916_CR17","doi-asserted-by":"crossref","first-page":"318","DOI":"10.4049\/jimmunol.125.1.318","volume":"125","author":"M. Rizzetto","year":"1980","unstructured":"Rizzetto M., Shih J. W. K., Gerin J. L.: The hepatitis B virus-associated delta antigen (delta); isolation from liver, development of a solid-phase radioimmunoassay for delta\/anti-delta, and partial characterization of delta \u2014 J. Immunol.125, 318, 1980.","journal-title":"J. Immunol."},{"key":"BF02886916_CR18","doi-asserted-by":"crossref","first-page":"437","DOI":"10.7326\/0003-4819-98-4-437","volume":"98","author":"M. Rizzetto","year":"1983","unstructured":"Rizzetto M., Verme G., Recchia S., Bonino F., Farci P., Aric\u00f2 S., Calzia R., Picciotto A., Colombo M., Popper H.: Chronic HBsAg hepatitis with intrahepatic expression of the delta antigen. An active and progressive disease unresponsive to immunosuppressive treatment \u2014 Ann. intern. Med.98, 437, 1983.","journal-title":"Ann. intern. Med."},{"key":"BF02886916_CR19","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0168-8278(85)80064-7","volume":"1","author":"J. M. Sanchez-Tapias","year":"1984","unstructured":"Sanchez-Tapias J. M., Vilar J. H., Costa J., Bruguera M., Ballesta A. M., Rodes J.: Natural history of chronic persistent hepatitis B. Relationship between hepatitis B virus replication and the course of the disease \u2014 J. Hepatol.1, 15, 1984.","journal-title":"J. Hepatol."},{"key":"BF02886916_CR20","unstructured":"Scully L. J., Brown D., Lloyd C., Shein R., Thomas H. C.: Immunologic studies before and during IFN therapy in chronic HBV infection: identification of factors predicting response \u2014 J. Hepatol. 1987. (In press)."},{"key":"BF02886916_CR21","first-page":"5329","volume":"2","author":"L. J. Scully","year":"1965","unstructured":"Scully L. J., Shein R., Lok A. S. F., Karayiannis P., Thomas H. C.: Lymphoblastoid IFN therapy of chronic hepatitis B virus infection. Different racial response \u2014 J. Hepatol.2, 5329, 1965. (Abstract).","journal-title":"J. Hepatol."},{"key":"BF02886916_CR22","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1002\/hep.1840060612","volume":"6","author":"A. Smedile","year":"1986","unstructured":"Smedile A., Rizzetto M., Denniston K., Bonino F., Wells F., Verme G., Consolo F., Hoyer B., Purcell R. H., Gerin J. L.: Type D hepatitis: the clinical significance of hepatitis D virus RNA in serum as detected by a hybridization based assay \u2014 Hepatology6, 1297, 1986.","journal-title":"Hepatology"},{"key":"BF02886916_CR23","first-page":"450","volume":"2","author":"C. A. Spina","year":"1983","unstructured":"Spina C. A., Fahey J. L., Durkos Smith D., Dorey F., Sarna G.: Suppression of NK cell cytotoxicity in peripheral blood of patients receiving interferon therapy \u2014 J. biol. Res. Modif.2, 450, 1983.","journal-title":"J. biol. Res. Modif."},{"key":"BF02886916_CR24","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/j.1365-3083.1981.tb00185.x","volume":"14","author":"H. S. Warren","year":"1981","unstructured":"Warren H. S.: The generation of specific cytotoxic responses by human lymphocytes requires antigen and activities provided by a lymphokine supernatant \u2014 Scand. J. Immunol.14, 71, 1981.","journal-title":"Scand. J. Immunol."}],"container-title":["La Ricerca in Clinica e in Laboratorio"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02886916.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/BF02886916\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02886916.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T10:39:36Z","timestamp":1674038376000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/BF02886916"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1987,9]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1987,9]]}},"alternative-id":["BF02886916"],"URL":"https:\/\/doi.org\/10.1007\/bf02886916","relation":{},"ISSN":["0390-5748"],"issn-type":[{"value":"0390-5748","type":"print"}],"subject":[],"published":{"date-parts":[[1987,9]]}}}